61/100
overall score
Total issues found:
141341Updated on: November 27, 2024
Data we analyse
Phishing and malware
139609
issues
Network security
136
issues
Email security
12
issues
Website security
1584
issues
Recent critical risk issues we found
173 corporate credentials stolen
21% employees reuse breached passwords
1505 SSL configuration issues found
25 critical vulnerabilities found
What information we check
Software patching
Web application security
Email security
Dark web exposure
Cybersecurity Benchmark
A comparison of this company’s cybersecurity ranking with industry averages and peer organizations
Phishing and malware
0
vs.
41
Network security
90
vs.
91
Email security
89
vs.
71
Website security
61
vs.
65
Get Your Free Report
Need help in fixing issues? Contact us and we will help you prepare an action plan to improve your risk rating.
Company overview
Novo Nordisk (novonordisk.com) is a global healthcare company headquartered in Bagsværd, Denmark, specializing in the research, development, manufacturing and marketing of pharmaceutical products and medical devices. Best known for diabetes and obesity treatments, the company also develops therapies for hemophilia, growth disorders and other serious chronic conditions. Novo Nordisk operates extensive R&D and manufacturing facilities worldwide and supplies therapies to healthcare systems across multiple markets.
Details
Website:
Industries:
Manufacturing
Company size:
10,001+ employees
Founded:
1923
Headquarters:
Novo Alle; Bagsværd, 2880, DK
Outcome reliability
We analyze billions of signals from publicly available sources to deliver validated insights into how your company is perceived externally by threat actors. These insights help security teams respond more quickly to risks, manage zero-day incidents effectively, and reduce overall exposure.
